MA-LI WONG, MD
Psychiatric in Miami, FL
License number
Florida ME98288
Category
Psychiatric
Type
Psychiatry
Address
Address
1611 M851, Miami, FL 33136
Phone
(305) 355-9105
(305) 243-8470 (Fax)
(305) 243-8470 (Fax)
Organization information
See more information about MA-LI WONG at bizstanding.comMa-Li Wong MD
1580 NW 10 Ave, Miami, FL 33136
Industry:
Psychiatrist
Phone:
(305) 243-4727 (Phone)
Ma-Li Li Wong
Professional information
Dr. Ma-Li Wong, Miami FL - MD (Doctor of Medicine)
Specialties:
Psychiatry
Address:
1611 NW 12Th Ave SUITE 16690, Miami 33136
(305) 355-9105 (Phone), (305) 243-8470 (Fax)
(305) 355-9105 (Phone), (305) 243-8470 (Fax)
Languages:
English
Hospitals:
1611 NW 12Th Ave SUITE 16690, Miami 33136
Jackson Memorial Hospital
1611 West 12Th Ave, Miami 33136
Jackson Memorial Hospital
1611 West 12Th Ave, Miami 33136
Education:
Medical School
Universidade De Sao Paulo, Faculdade De Medicina
Universidade De Sao Paulo, Faculdade De Medicina
Compositions And Methods For Determining And Predicting Treatment Responses For Depression And Anxiety
US Patent:
2008011, May 22, 2008
Filed:
Aug 12, 2005
Appl. No.:
11/573689
Inventors:
Julio Licinio - Miami FL, US
Ma-Li Wong - Miami FL, US
Kristopher J.L. Irizarry - Sugarloaf CA, US
Katherine Misouras Irizarry - Sugarloaf CA, US
Ma-Li Wong - Miami FL, US
Kristopher J.L. Irizarry - Sugarloaf CA, US
Katherine Misouras Irizarry - Sugarloaf CA, US
Assignee:
THE REGENTS of the University of California - Oakland CA
International Classification:
C12Q 1/68, G01N 33/574
US Classification:
435 6, 435 721
Abstract:
The invention provides genetic means, including compositions (e.g., kits) and methods, to predict the efficacy of a treatment in depression and anxiety and to predict a patient's response to a particular a specific medication or treatment. The invention provides methods for diagnosing the presence of a psychiatric disorder or determining the outcome of a treatment for a psychiatric disorder. The invention provides methods for methods for diagnosing the presence of a psychiatric disorder in an individual by determining what corticotropin-releasing hormone receptor 1 (CRHR1) protein or transcript isoforms are expressed in an individual. The invention provides methods for diagnosing the presence of a psychiatric disorder in an individual by determining what protein or transcript isoforms are expressed in an individual wherein the protein is involved in the hypothalamic-pituitary-adrenal (HPA) axis pathway.